These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23099494)

  • 1. Aligning scan locations from consecutive spectral-domain optical coherence tomography examinations: a comparison among different strategies.
    Giani A; Pellegrini M; Invernizzi A; Cigada M; Staurenghi G
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7637-43. PubMed ID: 23099494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of retinal nerve fiber layer measurement between 2 spectral domain OCT instruments.
    Tan BB; Natividad M; Chua KC; Yip LW
    J Glaucoma; 2012; 21(4):266-73. PubMed ID: 21637116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography in retinitis pigmentosa: reproducibility and capacity to detect macular and retinal nerve fiber layer thickness alterations.
    Garcia-Martin E; Pinilla I; Sancho E; Almarcegui C; Dolz I; Rodriguez-Mena D; Fuertes I; Cuenca N
    Retina; 2012 Sep; 32(8):1581-91. PubMed ID: 22922847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of macular thickness measurements between time-domain and spectral-domain optical coherence tomographies in eyes with and without macular abnormalities.
    Giammaria D; Ioni A; Bartoli B; Cofini V; Pellegrini G; Giannotti B
    Retina; 2011 Apr; 31(4):707-16. PubMed ID: 21836402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cataract surgery on repeatability and measurements of spectral domain optical coherence tomography.
    Bambo MP; Garcia-Martin E; Otin S; Sancho E; Fuertes I; Herrero R; Satue M; Pablo L
    Br J Ophthalmol; 2014 Jan; 98(1):52-8. PubMed ID: 24174613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.
    Wolf-Schnurrbusch UE; Ceklic L; Brinkmann CK; Iliev ME; Frey M; Rothenbuehler SP; Enzmann V; Wolf S
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3432-7. PubMed ID: 19234346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
    Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
    Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instruments.
    Heussen FM; Ouyang Y; McDonnell EC; Narala R; Ruiz-Garcia H; Walsh AC; Sadda SR
    Br J Ophthalmol; 2012 Mar; 96(3):380-5. PubMed ID: 21733920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved repeatability of retinal thickness measurements using line-scan ophthalmoscope image-based retinal tracking.
    Hu J; Gottlieb CB; Barajas DJ; Barnett CJ; Schoenholz T; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):310-4. PubMed ID: 25856815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility and repeatability of Cirrus and Spectralis Fourier-domain optical coherence tomography of healthy and epiretinal membrane eyes.
    Pinilla I; Garcia-Martin E; Fernandez-Larripa S; Fuentes-Broto L; Sanchez-Cano AI; Abecia E
    Retina; 2013; 33(7):1448-55. PubMed ID: 23538575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of macular thickness measurements using Cirrus SD-OCT in neovascular age-related macular degeneration.
    Parravano M; Oddone F; Boccassini B; Menchini F; Chiaravalloti A; Schiavone M; Varano M
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4788-91. PubMed ID: 20435585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments.
    Pierro L; Giatsidis SM; Mantovani E; Gagliardi M
    Am J Ophthalmol; 2010 Aug; 150(2):199-204.e1. PubMed ID: 20570233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality and reproducibility of retinal thickness measurements in two spectral-domain optical coherence tomography machines.
    Krebs I; Smretschnig E; Moussa S; Brannath W; Womastek I; Binder S
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6925-33. PubMed ID: 21791591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of macular thickness measurement among five OCT instruments: effects of image resolution, image registration, and eye tracking.
    Chin EK; Sedeek RW; Li Y; Beckett L; Redenbo E; Chandra K; Park SS
    Ophthalmic Surg Lasers Imaging; 2012; 43(2):97-108. PubMed ID: 22201525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).
    Grover S; Murthy RK; Brar VS; Chalam KV
    Am J Ophthalmol; 2009 Aug; 148(2):266-71. PubMed ID: 19427616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normative data set identifying properties of the macula across age groups: integration of visual function and retinal structure with microperimetry and spectral-domain optical coherence tomography.
    Sabates FN; Vincent RD; Koulen P; Sabates NR; Gallimore G
    Retina; 2011; 31(7):1294-302. PubMed ID: 21358460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral-domain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis.
    Gupta V; Gupta P; Singh R; Dogra MR; Gupta A
    Am J Ophthalmol; 2008 Jun; 145(6):1018-1022. PubMed ID: 18343349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness.
    Kiernan DF; Hariprasad SM; Chin EK; Kiernan CL; Rago J; Mieler WF
    Am J Ophthalmol; 2009 Feb; 147(2):267-275.e2. PubMed ID: 18929353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema.
    ; Bressler SB; Edwards AR; Chalam KV; Bressler NM; Glassman AR; Jaffe GJ; Melia M; Saggau DD; Plous OZ
    JAMA Ophthalmol; 2014 Sep; 132(9):1113-22. PubMed ID: 25058482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is quantitative spectral-domain superior to time-domain optical coherence tomography (OCT) in eyes with age-related macular degeneration?
    Eriksson U; Alm A; Larsson E
    Acta Ophthalmol; 2012 Nov; 90(7):620-7. PubMed ID: 21371288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.